Infectious Disease
Infectious Disease Database
106 conditions across 12 systems — empiric and targeted regimens, PCN allergy alternatives, pediatric & pregnancy dosing, resistance notes, infectious rashes. IDSA, CDC, ATS, SSC 2024–2026.
Cardiology
Cardiovascular Guidelines
35 conditions — ACS management, acute heart failure, arrhythmias, pericarditis & myocarditis, torsades / long-QT, Takotsubo, Brugada, RV infarction, mechanical complications of MI, hypertensive emergency, PE, and more. ACC/AHA 2024–2026.
Pulmonology
Pulmonary Guidelines
19 conditions — COPD exacerbation, asthma, acute chest syndrome, aspiration & viral/COVID pneumonia, foreign-body aspiration, HAPE, respiratory failure, pneumothorax, pleural disease, and more. ATS/ERS 2024–2026.
Neurology
Neurological Guidelines
29 conditions — acute ischemic stroke, hemorrhagic stroke, SAH, seizure, status epilepticus, TIA, ICP management, and meningitis. AHA/ASA 2024–2026.
Orthopedics
Orthopedic Guidelines
32 conditions — fractures (hip, distal radius, ankle, scaphoid, femoral shaft, tibial plateau, supracondylar pediatric + more), dislocations (shoulder, hip, patella, elbow, knee, Lisfranc, perilunate/lunate), infections & conditions (septic arthritis, osteomyelitis, gout, compartment syndrome). AAOS, PROFHER, OVIVA, ACR, TARSALS 2020–2025.
Gastroenterology
GI Guidelines
27 conditions — upper and lower GI bleeding, acute pancreatitis, bowel obstruction, mesenteric ischaemia, acute liver failure, hepatic encephalopathy, IBD flares, and more. ACG, AASLD, BSG 2024–2026.
Toxicology
Toxicology Guidelines
30 conditions — antidote protocols and overdose management for acetaminophen, opioids, TCAs, digoxin, iron, lithium, sulfonylureas, beta-blockers, calcium channel blockers, carbon monoxide, cyanide, methemoglobinemia, anticholinergics, LAST, hydrofluoric acid, and more. 2024–2026.
Trauma & Surgery
Trauma Guidelines
14 conditions — haemorrhagic shock, damage control resuscitation, TBI management, chest trauma, pelvic fractures, REBOA, MTP, abdominal trauma, and surgical emergencies. ATLS, EAST, WTA 2024–2026.
Endocrinology
Endocrine Guidelines
14 conditions — DKA, euglycaemic DKA, HHS, adrenal crisis, thyroid storm, thyrotoxic periodic paralysis, refeeding syndrome, myxoedema coma, hypoglycaemia, hypercalcaemia, and more. ADA, AACE, Endocrine Society 2024–2026.
Hematology / Oncology
Hematology Guidelines
28 conditions — anticoagulation reversal, massive transfusion, sickle cell crises, TTP/HUS, DIC, neutropenic fever, and oncologic emergencies. ASH 2024–2026.
Nephrology
Renal Guidelines
31 conditions — AKI, CKD complications, acid-base disturbances, electrolyte emergencies, hypertensive nephropathy, nephrotic/nephritic syndromes, rhabdomyolysis, contrast nephropathy, and dialysis emergencies. KDIGO, ERA, ASN 2024–2026.
OB/GYN
Obstetric & Gynecologic Guidelines
22 conditions — Eclampsia, PPH, HELLP, ectopic pregnancy, placental abruption, cord prolapse, shoulder dystocia, ovarian torsion, and more. ACOG 2024.
Psychiatry
Psychiatric & Behavioral Emergencies
5 protocol modules — Verbal de-escalation (BARS), Pharmacological management with weight-based dosing, Special populations (ExDS, ETOH, pregnancy, elderly), Capacity & legal (involuntary holds, ITA), and C-SSRS suicide risk assessment. Project BETA / APA 2024.
Ophthalmology
Ophthalmology Guidelines
42 conditions across 6 urgency tiers — vision-threatening emergencies (CRAO, GCA, AACG, retrobulbar hematoma + canthotomy, open globe, chemical burn), neuro-ophthalmologic palsies, trauma, infections, and pediatric findings. AAO PPP 2024.
Dermatology
Dermatologic Emergencies
16 conditions — SJS/TEN, DRESS, AGEP, erythroderma, necrotizing fasciitis, purpura fulminans, angioedema, urticaria / anaphylaxis cutaneous findings, cellulitis vs pseudocellulitis, herpes zoster complications, and more. AAD / EADV 2024–2026.
ENT
Otolaryngology Guidelines
15 conditions — epistaxis (anterior + posterior), peritonsillar / retropharyngeal / Ludwig's angina, deep neck space infections, acute otitis media/externa, mastoiditis, sudden sensorineural hearing loss, acute vestibular syndromes, ENT foreign body, airway compromise, sialadenitis, and more. AAO-HNS 2024–2026.